about
Consequences of menopause in women with diabetes mellitus - a clinical problem.Clinical aspects of obesity in the gynecological endocrinologicaly practice.Evaluation of sex hormone levels and some metabolic factors in men with coronary atherosclerosis.Polish Society of Endocrinology Position statement on endocrine disrupting chemicals (EDCs).beta(3)-adrenergic receptor polymorphism and metabolic syndrome in postmenopausal women.Cardiovascular disease risk factors associated with low level of physical activity in postmenopausal Polish women.Classic PCOS phenotype is not associated with deficiency of endogenous vitamin D and VDR gene polymorphisms rs731236 (TaqI), rs7975232 (ApaI), rs1544410 (BsmI), rs10735810 (FokI): a case-control study of lower Silesian women.Effects of radioiodine administration on serum concentrations of matrix metalloproteinases, adiponectin and thrombospondin-1.Waist circumference and serum adiponectin levels in obese and non-obese postmenopausal women.Vitamin D receptor gene polymorphism and cardiovascular risk variables in elderly Polish subjects.Relationship of PPARgamma2 polymorphism with obesity and metabolic syndrome in postmenopausal Polish women.Relationship between vitamin D receptor BsmI and FokI polymorphisms and anthropometric and biochemical parameters describing metabolic syndrome.Plasma adiponectin concentration in relation to severity of coronary atherosclerosis and cardiovascular risk factors in middle-aged men.Sex steroids concentrations in relation to bone mineral density in men with coronary atherosclerosis.Climacteric obesity: from genesis to clinic.Left ventricular function impairment in patients with normal-weight obesity: contribution of abdominal fat deposition, profibrotic state, reduced insulin sensitivity, and proinflammatory activation.Oral administration of kaempferol inhibits bone loss in rat model of ovariectomy-induced osteopenia.Are endocannabinoid type 1 receptor gene (CNR1) polymorphisms associated with obesity and metabolic syndrome in postmenopausal Polish women?Effects of long-term administration of pantoprazole on bone mineral density in young male rats.Association of serum glypican-4 levels with cardiovascular risk predictors in women with polycystic ovary syndrome - a pilot study.Lipid accumulation product (LAP) as a criterion for the identification of the healthy obesity phenotype in postmenopausal womenSelected CNR1 polymorphisms and hyperandrogenemia as well as fat mass and fat distribution in women with polycystic ovary syndromeIntralaryngeal ectopic thyroidADRB3andPPARγ2gene polymorphisms and their association with cardiovascular disease risk in postmenopausal womenEffect of moderate-intensity exercise on oxidative stress indices in metabolically healthy obese and metabolically unhealthy obese phenotypes in postmenopausal womenAndrogen receptor polymorphism and platelet reactivity in healthy menPost-exercise oxidative stress and obesity in postmenopausal women: The role ofbeta3-adrenergic receptor polymorphismPremenstrual syndrome: From etiology to treatmentQuantitative Ultrasound of the Heel and Some Parameters of Bone Turnover in Patients with AcromegalyBombesin plasma levels in patients with benign and malignant breast disease
P50
Q36350792-89FF6636-A332-4705-929F-62C2BC782D4BQ36594328-EA6A0F8B-50D8-40AE-806F-2A8C8174F8A2Q38515336-7B9528D7-4F85-4251-AD72-1EAF6C7220D5Q38542005-EEE070D1-A1E1-4D17-B4E9-0717C07F1D01Q39838542-C49A6647-4957-4B9A-9B49-F9E078ED5743Q40118221-878BAC4A-9E60-4505-854C-66E234D78EC8Q41284401-DFE75A8E-DCC0-4510-B8DE-0FC2A2A6E2C0Q41820261-865CE090-EC60-4694-B3DF-3E4150035A31Q43224572-ED9A7AEA-E2AF-4844-A521-AD1CE7B17BC6Q43408785-3043C807-36BF-4644-B666-80F4BD9B5DF0Q45927105-2AABAF25-CC4A-4D12-AE05-C199CDD0093BQ46343599-87F7EBAC-BECE-434E-B92D-1D50633B7AD0Q46368034-72E4BE10-9B76-4E9B-B2EF-BED9DFE089AEQ46964328-2F4A16F5-1AFD-4638-8579-589ED79837FDQ46979543-991DA985-8C5C-4FB8-9D3F-75F5C409218FQ47322258-7FC41CAB-37CF-4895-8A07-405E471380C9Q47444513-60DFE81F-9ABD-4973-86AA-24CCCADED15DQ51391337-88D01CB0-D372-4F2A-90AF-8F7F20DCD63BQ51555781-E1F5D78D-9CB5-4959-8497-72329A667156Q53812906-AB5532CE-4ED7-44AE-8F83-DA427447D9F1Q57599349-32D72395-5CC0-441E-A7B8-5AE65DF37BA3Q57599352-7B61E3B9-6A17-46A4-8B97-0600A04C67B4Q57599354-5598F325-31E6-4EC2-B7C8-D7A91BF51489Q57599356-FFC8AB71-FC8F-4AAD-B887-A35515C5C3F4Q57599367-365AADBA-3038-4776-BFBB-C9167DC14F9FQ57599371-37CCE121-5A0D-4B6C-9D60-BC96A784D023Q57599381-1CEEE615-52F4-45CF-BB27-310DCD805462Q57599385-78BAAC11-2EB6-4009-9960-B9808761D4E1Q57599396-63C58584-8111-4AAE-8D56-C0973F6F2EA2Q57599400-6FD841C1-BC54-4384-8819-DB968BBD1FB7
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Diana Jedrzejuk
@ast
Diana Jedrzejuk
@en
Diana Jedrzejuk
@es
Diana Jedrzejuk
@nl
type
label
Diana Jedrzejuk
@ast
Diana Jedrzejuk
@en
Diana Jedrzejuk
@es
Diana Jedrzejuk
@nl
prefLabel
Diana Jedrzejuk
@ast
Diana Jedrzejuk
@en
Diana Jedrzejuk
@es
Diana Jedrzejuk
@nl
P106
P1153
6602960101
P21
P31
P496
0000-0001-7053-142X